Evidence map›Paper›PMID 35022023›Full record

ArticleBMC infectious diseases2022

Improving screening and management of latent tuberculosis infection: development and evaluation of latent tuberculosis infection primary care model.

Marina Kunin, Mark Timlin, Chris Lemoh, David A Sheffield, Alana Russo, Shegofa Hazara, Jacqueline McBride

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 3 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 3 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Marina KuninMonash Health Refugee Health and Wellbeing, Monash Health, 122 Thomas Street, Dandenong, VIC, 3175, Australia. marina.kunin@monashhealth.org.ORCID http://orcid.org/0000-0002-8749-1134
Mark TimlinMonash Health Refugee Health and Wellbeing, Monash Health, 122 Thomas Street, Dandenong, VIC, 3175, Australia.
Chris LemohMonash Health Refugee Health and Wellbeing, Monash Health, 122 Thomas Street, Dandenong, VIC, 3175, Australia.
David A SheffieldMonash Health Refugee Health and Wellbeing, Monash Health, 122 Thomas Street, Dandenong, VIC, 3175, Australia.
Alana RussoMonash Health Refugee Health and Wellbeing, Monash Health, 122 Thomas Street, Dandenong, VIC, 3175, Australia.
Shegofa HazaraMonash Health Refugee Health and Wellbeing, Monash Health, 122 Thomas Street, Dandenong, VIC, 3175, Australia.
Jacqueline McBrideMonash Health Refugee Health and Wellbeing, Monash Health, 122 Thomas Street, Dandenong, VIC, 3175, Australia.
Monash Health · AUMonash Medical Centre · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn Australia, demand for specialist infectious diseases services exceeds capacity to provide timely management of latent tuberculosis infection (LTBI) in areas of high refugee and asylum seeker settlement. A model for treating LTBI patients in primary care has been developed and piloted in a refugee-focused primary health service (Monash Health Refugee Health and Wellbeing [MHRHW]) and a universal primary care clinic. This study reports on the development and evaluation of the model, focusing on the model feasibility, and barriers and enablers to its success.

methodsA convergent mix-methods design was used to evaluate the model for treating LTBI patients in primary care, where a prospective cohort study of patients commencing treatment either at MHRHW or the universal primary care clinic determined the model feasibility, while focus groups with clinicians directly involved in treating these patients explored barriers and enablers to sustainability and success of the model.

resultsFrom January 2017 to April 2018, 65 patients with confirmed LTBI presented at participating clinics. Treatment was accepted by 31 (48%) patients, of whom 15(48%) were treated at MHRHW and 16 (52%) at the universal primary care clinic. The 6-months' treatment completion rate was higher at MHRHW compared to the universal primary care clinic (14 (93%) compared to 9 (56%) respectively, p = 0.0373). Reasons for non-completion included adverse reaction, opting out and relocation. At the completion of the pilot, 15 clinicians participated in two focus groups. Clinicians identified barriers and enablers for successful LTBI management at patient, provider, organisational and clinical levels. While barriers for treatment completion and adherence were consistent across the two pilot sites, enablers, such as resources to facilitate patient education and follow-up, were available only at MHRHW.

conclusionScreening and management of LTBI patients can be achieved within the primary care setting, considerate of barriers and enablers at patient, provider, organisational and clinical levels. Upscaling of a primary care response to the management of LTBI will require supporting primary care clinics with resources to employ dedicated clinical staff for patient education, follow-up communication and monitoring medication adherence.

Indexed as

Latent TuberculosisRefugeesAntitubercular AgentsHumansMass ScreeningPrimary Health CareProspective StudiesAntitubercular AgentsCulturally and linguistically diverse populationsHealth care deliveryHealth care evaluationHealth plan implementationLatent tuberculosis infectionPatient educationPrimary careRefugee health

Identifiers

PMID35022023
PMCPMC8756639
OpenAlexW4205289635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.